The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis-Reference-Cited by-同舟云学术

The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis

Published:2022-01 Issue:1 Volume:18 Page:61-72
ISSN:1551-7136
Container-title:Heart Failure Clinics
language:en
Short-container-title:Heart Failure Clinics

Author:

Palmiero Giuseppe,Vetrano Erica,Rubino Marta,Monda Emanuele,Dongiglio Francesca,Lioncino Michele,Di Fraia Francesco,Caiazza Martina,Verrillo Federica,Capodicasa Laura,Cerciello Giuseppe,Manganelli Fiore,Catalano Mara,D'Arienzo Davide,De Rimini Maria Luisa,Ascione Raffaele,Golino Paolo,Caso Pio,Ascione Luigi,Limongelli Giuseppe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference108 articles.

1. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee;Benson;Amyloid,2018

2. Molecular mechanisms of amyloidosis;Merlini;N Engl J Med,2003

3. A modern primer on light chain amyloidosis in 592 patients with mass spectrometry-verified typing;Muchtar;Mayo Clin Proc,2019

4. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38a MAPK pathway;Shi;Proc Natl Acad Sci U S A,2010

5. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review;Ruberg;J Am Coll Cardiol,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis;Heart Failure Clinics;2024-07

2. Genotype-Phenotype Correlations in ATTR Amyloidosis;Heart Failure Clinics;2024-07

3. Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction;Journal of Clinical Medicine;2024-03-14

4. Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis;International Journal of Cardiology;2023-10

5. Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study;Orphanet Journal of Rare Diseases;2023-09-13